Rational development of oxyfluor™

Blood Substitutes

Volumn , Issue , 2006, Pages 298-311

  Shaw, Robert F ^a   Richard, Thomas J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882501867     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012759760-7/50036-6     Document Type: Chapter

References (42)

1. Clark L.C., Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966, 152:1755-1756.
2. Clark L.C., Shaw R.F. Stable emulsions of highly fluorinated organic compounds, US 5,684,050 1997.
3. Cochran R.P., Kunzelman K.S., Vocelka C.R., et al. Perfluorocarbon emulsion in the cardopulmonary bypass prime reduces neurologic injury. Ann. Thorac. Surg. 1997, 63(5):3126.
4. Costa-Gomez M.F., Deschamps J., Menz D.-H. Solubility of dioxygen in seven fluorinated liquids. J. Fluor. Chem. 2004, 125:1325-1329.
5. Flaim S.F. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Artif. Cells Blood Subst. Immob. Biotech. 1994, 22(4):1043-1054.
6. Geyer R.P., Monroe R.G., Taylor K. Survival of rats totally perfused with a fluorocarbon-detergent preparation. Organ Perfusion and Preservation 1968, 85-96. Appleton-Century-Crofts, New York. J.C. Norman, J. Folkman, W.G. Hardison (Eds.).
7. Geyer R.P., Taylor K., Duffett E., et al. Successful complete replacement of the blood of living rats with artificial substitutes. Fed. Proc. 1973, 32:927-929.
8. Gjaldbaek J., Hildebrand J.H. The solubility of nitrogen in carbon disulfide, benzene, normal and cyclo-hexane and in three fluorocarbons. J. Am. Chem. Soc. 1949, 71:3147-3150.
9. Goodin T.H., Kaufman R.J. Method of pretreating an animal with a corticosteroid prior to infusion of a perfluorochemical emulsion, US 5,670,495 1997.
10. Goodin T.H., Grossbard E.B., Kaufman R.J., et al. A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study. Crit. Care Med. 1994, 22(4):680-689.
11. Gould S., Rosen A., Sehgal L., et al. Fluosol-DA as a red-cell substitute in acute anemia. N. Engl. J. Med. 1986, 314(26):1653-1656.
12. Herren J.I., Kunzelman K.S., Vocelka C., et al. Angiographic and histological evaluation of porcine retinal vascular damage and protection with perfluorocarbons after massive air embolism. Stroke 1998, 29:2396-2403.
13. Hill S.E., Leone B.J., Faithfull N.S., et al. Perflubron emulsion (AF0144) augments harvesting of autologous blood: a phase II study in cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2002, 16(5):555-560.
14. Kaufman R.J., Goodin T.H., Richard T.J. Efficacy of perfluorochemical emulsions in surgical anemia and shock resuscitation. Poster F4, Fifth International Symposium on Blood Substitutes 1993.
15. Kaufman R.J., Richard T.J., Moore G.G.I., Flynn R.M. Highly fluorinated, chlorosubstituted organic compound containing emulsions and methods of making and using them, US 5,785,950 1998.
16. Krafft M.P., Postel M., Riess J.G. Drop size stability assessment of fluorocarbon emulsions. Biomat. Artif. Cells Immob. Biotech. 1992, 20(2-4):865-868.
17. Le T.D., Arlauskas R.A., Weers J.G. Charaterization of the lipophilicity of fluorocarbon derivatives containing halogens or hydrocarbon building blocks. J. Fluor. Chem. 1996, 78:155-163.
18. Long D.M. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use, US 4,987,154 1991.
19. Mitsuno T., Ohyanagi H., Yokoyama K. Development of a perfluorochemical emulsion as a blood gas carrier. Artif. Organs 1984, 8(1):25-33.
20. Mitten R.M., Burgan A.R., Hamlin A., et al. Dose related biodistribution & elimination of 100% PFOB emulsion. Biomat. Artif. Cells Artif. Organs 1988, 16(1-3):683-684.
21. Moore G.G.I., Flynn R.M., Guerra M.A. Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use, US 5,567,765 1996.
22. Ni Y., Pelura T.J., Sklenar T.A., et al. Effect of formulation, processing and storage parameters on the characteristics and stability of perflubron emulsion. Artif. Cells Blood Subst. Immob. Biotech. 1994, 22(4):1307-1315.
23. Pelura T.J., Johnson C.S., Tarara T.E., Weers J.G. Stabilization of perflubron emulsions with egg yolk phospholipid. Biomat. Artif. Cell Immob. Biotech. 1992, 20(2-4):845-848.
24. Postel M., Riess J.G., Weers J.G. Fluorocarbon emulsions-the stability issue. Artif. Cells Blood Subst. Immob. Biotech. 1994, 22(4):991-1005.
25. Riess J.G. Fluorocarbon-based oxygen delivery: basic principles and product development. Blood Substitutes: Principles, Methods, Products and Clinical Trials 1998, 101-126. Karger Landes Systems, New York. T.M.S. Chang (Ed.).
26. Riess J.G. Oxygen carriers ('blood substitutes')-raison d'être, chemistry, and some physiology. Chem. Rev. 2001, 101:2797-2919.
27. Riess J.G., Dalfors J.L., Hanna G.K., et al. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. Biomat. Artif Cells Blood Subst. Immob. Biotech. 1992, 20(2-4):839-842.
28. Rosoff J.D., Soltow L.O., Vocelka C.R., et al. A second generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass. J. Cardiothor. Vasc. Anesth. 1998, 12:397-401.
29. Simon J.H. Scientific and utilitarian value of fluorine chemistry. Ind. Eng. Chem. 1947, 39:238-241.
30. Sloviter H., Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967, 216:458-460.
31. Song D., Pelura T.J., Liu J., Ni Y. Effects of buffer pH and phosphate concentration on the droplet size and EYP hydrolysis of perflubron EYP emulsions. Artif. Cells Blood Subst. Immob. Biotech. 1994, 22(4):1299-1305.
32. Spahn D.R., Washcke K.F., Standl T., et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss-non-cardiac surgery: results of a European phase 3 study. Anesthesiology 2002, 97(6):1338-1349.
33. Tremper K.K., Vercelotti G., Hammerschmidt D.E. Hemodynamic profile of adverse clinical reactions to Fluosol-DA 20%. Crit Care Med. 1984, 12:428-431.
34. Tsuda Y., Yamanouchi K., Yokoyama K., et al. Discussion and considerations for the excretion mechanism of perfluorochemical emulsion. Biomat. Artif. Cells Artif. Organs 1988, 16(1-3):473-483.
35. Weers J.G., Fields T., Resch P., et al. Room temperature stable perfluorocarbon emulsions with acceptable half-lives in the reticuloendothelial system. Artif. Cells Blood Subst. Immob. Biotech. 1994, 22(4):1175-1182.
36. Wretlind A. Method of preparing intravenously injectable fat emulsions free from side reactions or complications, US 3,169,094 1965.
37. Wretlind A. Development of fat emulsions. J. Parenteral Enteral Nutr. 1981, 5(3):230-235.
38. Yamanouchi K., Tanaka M., Tsuda Y., et al. Quantitative structure-in vivo half-life relationships of perfluorochemicals for use as oxygen transporters. Chem. Pharm. Bull. 1985, 33(3):1221-1231.
39. Yokoyama K., Yamanouchi K., Murashima R. Excretion of perfluorochemicals after intravenous injection of their emulsion. Chem. Pharm. Bull. 1975, 23:1368-1373.
40. Yokoyama K., Yamanouchi K., Ohyanagi H., Mitsuno T. Fate of perfluorochemicals in animals after intravenous injection or hemodilution with their emulsions. Chem. Pharm. Bull. 1978, 26:956-966.
41. Yokoyama K., Suyama T., Okamoto H., et al. A perfluorochemical emulsion as an oxygen carrier. Artif. Organs 1984, 8(1):34-40.
42. Yong N., Klein D.H., Song D. Recent developments in pharmacokinetic modeling of perfluorocarbon emulsions. Artif. Cells Blood Subst. Immob. Biotech. 1996, 24(2):81-90.